Neyazi, Sina
Yamazawa, Erika
Hack, Karoline
Tanaka, Shota
Nagae, Genta
Kresbach, Catena
Umeda, Takayoshi
Eckhardt, Alicia
Tatsuno, Kenji
Pohl, Lara
Hana, Taijun
Bockmayr, Michael
Kim, Phyo
Dorostkar, Mario M.
Takami, Toshihiro
Obrecht, Denise
Takai, Keisuke
Suwala, Abigail K.
Komori, Takashi
Godbole, Shweta
Wefers, Annika K.
Otani, Ryohei
Neumann, Julia E.
Higuchi, Fumi
Schweizer, Leonille
Nakanishi, Yuta
Monoranu, Camelia-Maria
Takami, Hirokazu
Engertsberger, Lara
Yamada, Keisuke
Ruf, Viktoria
Nomura, Masashi
Mohme, Theresa
Mukasa, Akitake
Herms, Jochen
Takayanagi, Shunsaku
Mynarek, Martin
Matsuura, Reiko
Lamszus, Katrin
Ishii, Kazuhiko
Kluwe, Lan
Imai, Hideaki
von Deimling, Andreas
Koike, Tsukasa
Benesch, Martin
Kushihara, Yoshihiro
Snuderl, Matija
Nambu, Shohei
Frank, Stephan
Omura, Takaki
Hagel, Christian
Kugasawa, Kazuha
Mautner, Viktor F.
Ichimura, Koichi
Rutkowski, Stefan
Aburatani, Hiroyuki
Saito, Nobuhito
Schüller, Ulrich http://orcid.org/0000-0002-8731-1121
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
Fördergemeinschaft Kinderkrebs-Zentrum Hamburg
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 5 October 2023
Revised: 28 November 2023
Accepted: 12 December 2023
First Online: 24 January 2024
Declarations
:
: SR is at the Advisory Board of Bayer, Novartis, BMS and Roche, at the Data Monitoring and Safety Committee of Celgene, performs assessment for the German Children`s Cancer Foundation and consulting for MyChildsCancer.